Femasys (FEMY) Research & Development (2020 - 2025)
Femasys' (FEMY) quarterly Research & Development came in at $984977.0 in Q2 2025, down 50.15% YoY from $2.0 million in Q2 2024, and up 2.69% on a QoQ basis from $959162.0 in Q1 2025.
Femasys (FEMY) Research & Development (2020 - 2025) Analysis & Trends
Femasys (FEMY) has 6 years of Research & Development data on file, last reported at $984977.0 in Q2 2025.
- Quarterly Research & Development fell 50.15% year-over-year to $984977.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $9.6 million (down 5.41% YoY) and the FY2025 annual result came in at $7.6 million, down 7.78% from the prior year.
- Research & Development advanced to $984977.0 in Q2 2025, from $959162.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $6.8 million in Q4 2023 to a low of -$2.8 million in Q4 2021.
- A 5-year average of $1.2 million and a median of $927015.0 in 2021 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 6586.1% in 2021, down 9953.79% in 2021.
- Tracing FEMY's Research & Development over 5 years: stood at -$2.8 million in 2021, then surged by 145.06% to $1.3 million in 2022, then surged by 431.93% to $6.8 million in 2023, then retreated by 20.63% to $5.4 million in 2024, then slumped by 81.65% to $984977.0 in 2025.
- The last three Research & Development figures came in at $984977.0 (Q2 2025), $959162.0 (Q1 2025), and $5.4 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 984,977.00 |
| Mar 31, 2025 | 959,162.00 |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 6.76 Mn |
| Sep 30, 2023 | 70,883.00 |
| Jun 30, 2023 | 128,899.00 |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 90,374.00 |
| Jun 30, 2022 | 63,177.00 |
| Mar 31, 2022 | 68,863.00 |
| Dec 31, 2021 | -2.82 Mn |
| Sep 30, 2021 | 43,284.00 |
| Jun 30, 2021 | 894,868.00 |
| Mar 31, 2021 | 22,819.00 |
| Dec 31, 2020 | 28,636.00 |
| Sep 30, 2020 | 995,620.00 |